AI assistant
Sending…
DAVITA INC. — Director's Dealing 2012
Dec 6, 2012
30643_dirs_2012-12-06_7234fd81-e33c-4885-bffc-ec73f9df4494.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2012-12-05
Reporting Person: Mildenberger Laura (Chief People Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-05 | Common Stock | M | 15000 | $46.26 | Acquired | 16875 | Direct |
| 2012-12-05 | Common Stock | F | 6539 | $106.13 | Disposed | 10336 | Direct |
| 2012-12-05 | Common Stock | S | 8461 | $106.50 | Disposed | 1875 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-05 | Stock Appreciation Right | $46.26 | M | 15000 | Disposed | 2014-03-02 | Common Stock (15000) | Direct |
Footnotes
F1: Stock Appreciation Right, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, 8.33% on the 20th month following the grant date, and 8.33% every four months thereafter.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25